Patient Education Sheet Library
Search Results
Capecitabine
Capecitabine is used to treat breast, colorectal, gastric, esophageal, and pancreatic cancer.
Treatment Taken by Mouth
Download (English) – 0.51MBCapecitabine and Cisplatin
The combination of capecitabine and cisplatin is used for anal cancer, stomach cancer, and esophagus…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Capecitabine and Mitomycin with Radiation Therapy
The combination of capecitabine and mitomycin with radiation therapy is used for anal cancer.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Capecitabine and Oxaliplatin (CAPOX, CAPEOX, XELOX)
The combination of capecitabine and oxaliplatin (CAPOX, CAPEOX, or XELOX) is used for many types…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Nivolumab, Capecitabine, and Cisplatin
The combination of nivolumab, capecitabine, and cisplatin is used for stomach and esophagus cancers.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Tislelizumab, Capecitabine, and Cisplatin
The combination of tislelizumab, capecitabine, and cisplatin is used for stomach cancer, esophagus cancer, and…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Pembrolizumab, Capecitabine, and Cisplatin
The combination of pembrolizumab, capecitabine, and cisplatin is used for stomach and esophagus cancers.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Lapatinib
Lapatinib is used to treat advanced or metastatic breast cancer that overexpresses human epidermal growth…
Treatment Taken by MouthNivolumab and CAPOX
The combination of nivolumab and CAPOX (capecitabine and oxaliplatin) is used for stomach cancer, esophagus…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Tislelizumab and CAPOX
The combination of tislelizumab and CAPOX (capecitabine and oxaliplatin) is used for stomach cancer, esophagus…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
